Earlier this year the Florida House of Representatives convened a work group to better understand the hemp-derived products industry in Florida. The work group consisted of regulators and industry participants alike, and the purpose of this group was to provide recommendations for a bill that would establish a regulatory framework for these products. House Bill 7027 (HB 7027) was the end product of the House’s work group.
HB 7027 elaborated on existing statutory language surrounding product packaging and labeling; it provided milligram caps and restrictions for a variety of hemp-derived product formulations including vaporizers, edibles, and beverages; and it included various sales restrictions regarding how and where hemp-derived products can be sold in Florida.
HB 7027 was not placed on the special-order calendar for 4/30, and if it is not heard today it will remain on the second reading calendar. From a procedural perspective, this means it would be extremely difficult to pass HB 7027 during the 2025 legislative session.
As many individuals testified during the House’s work group and during various committee hearings this year, Florida’s hemp industry craves regulations that balance consumer safety with market demand. Hopefully the legislative offseason provides industry members and elected officials with ample time to work together on a robust regulatory framework that allows this burgeoning industry the ability to continue thriving in Florida.
Special thanks to the lobbyists who advocate tirelessly for hemp and the hemp-derived products industry in Florida, you know who you are.